Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614445 · ClinicalTrials.gov registry record · Phase 3
The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy
A Phase 3 study, sponsored by Duchesnay.
- Completed
- Registry status
- Phase 3
- Development phase
- 280
- Enrollment target
NCT00614445 is a Phase 3 study that has completed, run by Duchesnay. The registered enrollment target is 280 participants.
The verdict
NCT00614445, a Phase 3 study, has completed, sponsored by Duchesnay.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 280 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Diclectin® (doxylamine succinate USP 10 mg and pyridoxine HCl 10 mg) is more effective at controlling the nausea and vomiting of pregnancy than a placebo.
Interventions
- DRUG Placebo
- DRUG doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00614445
The ClinicalTrials.gov registry entry for NCT00614445 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duchesnay, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00614445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00614445 about?
NCT00614445 is a clinical study titled "The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy". The purpose of this study is to determine whether Diclectin® (doxylamine succinate USP 10 mg and pyridoxine HCl 10 mg) is more effective at controlling the nausea and vomiting of pregnancy than a placebo.
What is the current status of trial NCT00614445?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 280 participants. The study started on 2008-01. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00614445?
The interventions under investigation include: Placebo (DRUG), doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mg (DRUG).
Who is sponsoring clinical trial NCT00614445?
This trial is sponsored by Duchesnay, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.